T1	p 61 107	outpatients with a major depressive disorder .
T2	p 189 224	outpatients with primary depression
T3	p 470 480	Depression
T4	i 33 57	doxepin versus bupropion
T5	i 165 185	bupropion to doxepin
T6	i 319 340	7-day placebo washout
T7	i 389 394	weeks
T8	i 405 416	treatment .
T9	i 676 683	Doxepin
T10	i 698 707	bupropion
T11	i 775 782	doxepin
T12	i 824 843	bupropion . Doxepin
T13	i 990 1001	bupropion .
T14	i 1076 1107	doxepin relative to bupropion .
T15	o 251 282	efficacy and safety differences
T16	o 417 440	Antidepressant response
T17	o 461 556	Hamilton Depression and Anxiety Scales , Clinical Global Severity and Improvement Ratings , and
T18	o 561 594	Zung Self-Rating Depression Scale
T19	o 608 616	efficacy
T20	o 722 734	sleep factor
T21	o 742 767	Hamilton Depression Scale
T22	o 863 904	incidence of anticholinergic side effects
T23	o 917 975	dry mouth , constipation , sleepiness , and tiredness , in
T24	o 1009 1043	increased appetite and weight gain